Abstract:BACKGROUND:Accumulating evidence has demonstrated the immunomodulatory effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis and the tumor microenvironment, besides its known capacity of specifically inducing the apoptosis of cancer cells. Mice are common available animal models for studying the roles of TRAIL. However, mice express only a single TRAIL receptor (mTRAILR) with an intracellular death domain, in contrast to the two TRAIL receptors (TRAILR1 and TRAILR2) in humans. Moreover, human TRAIL binds weakly to mTRAILR, whereas mouse TRAIL has a high affinity for human TRAIL-Rs. Therefore, we considered that murine TRAIL would be more suitable than human TRAIL for exploring the immunoregulatory effect of TRAIL in immunocompetent mice or when using mouse cells as the target. To our knowledge, the detailed method for the production of recombinant murine TRAIL has not been reported.OBJECTIVE:In this study, we aimed to design and express two soluble forms of murine TRAIL and verify the properties of the protein.METHODS:Recombinant murine TRAILs were expressed in Escherichia coli BL21 (DE3, and Nichelating affinity chromatography was used for protein purification. SDS-PAGE, GDS-PAGE and HPLC were applied to analyze the protein structure. The cytotoxicity of our purified murine TRAILs was evaluated in the TRAIL-sensitive human breast cancer ZR-75-30 cells and murine breast cancer 4T1 cells. Finally, validation of the tumor-killing ability of the murine protein in vivo.RESULTS:Two soluble forms of murine TRAILs (mT_N99 and mT_N188) were purified and demonstrated with high purity and trimeric structure. In addition, Zn2+ supplement was essential to produce soluble murine TRAILs in E.coli BL21 (DE3). The two purified soluble mTRAILs showed similar cytotoxicity to cancer cells, moreover, mT_N99 also showed a good anti-tumor effect in vivo and is more suitable for the treatment of murine tumor models.CONCLUSION:A production approach for recombinant murine TRAIL was determined, which covered the design of shortened forms, expression, purification and characterization.

Expression and Characterization of Human Tumor Necrosis Factor-Related Apoptosis Inducing Ligand in Methylotrophic Yeast Pichia Pastoris.

Fed-batch Production of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Soluble Form in Escherichia Coli and Its Purification and Characterization.

Targeted Expression of Green Fluorescent Protein/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Fusion Protein from Human Telomerase Reverse Transcriptase Promoter Elicits Antitumor Activity Without Toxic Effects on Primary Human Hepatocytes

Molecular Mechanisms of Resistance to TRAIL-induced Apoptosis in Tumor

[Expression of a DNA Fragment Encoding the Active Domain of Human TNF Related Apoptosis Inducing Ligand in Pichia Pastoris].

Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.

Expression of recombinant human soluble tumor necrosis factor related apoptosis inducing ligand using baculovirus

The Investigation of the Relationship Between Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Tumor Therapy

Expression, Purification and Characterization of Heterotrimeric Forms of Strail Using a Polycistronic Expression Vector.

[Cloning, Expression and Purification of Human TNF-related Apoptosis-Inducing Ligand in Escherichia Coli].

Production and Antitumor Activity of Soluble Human TRAIL

Eukaryotic Expression and in Vitro Tumor Cell Apoptosis-induced Effect of Human TRAIL

[Action of Apoptosis-Induced Ligand Gene in Relation to Tumor Necrosis Factor on Human Colon Cancer Cell Line HT29].

[Expression of TRAIL(114-281) Mediated by Adeno-Associated Virus and Its Tumoricidal Activity].

Antitumor Activity of Recombinant Soluble Human TRAIL

Expression of tumor necrosis factor receptor-immunoglobulin G1 Fc fusion protein in glycoengineered Pichia pastoris

Production of Soluble Murine TRAILs in Escherichia Coli with Zn2+ Supplementation

Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities

Construction of Pegr-Htrail Expression Vector Induced by Irradiation and Its Apoptosis in Tumor Cells in Vitro

Soluble Expression of TNF-Related Apoptosis-Inducing Ligand and Optimization of Its Purification Conditions